— Know what they know.
Not Investment Advice

TELA NASDAQ

TELA Bio, Inc.
1W: -9.5% 1M: +51.5% 3M: +45.0% YTD: +0.0% 1Y: -24.0% 3Y: -85.5% 5Y: -91.2%
$1.14
-0.11 (-8.80%)
 
Weekly Expected Move ±13.5%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Medical - Devices · Tech Score Buy · Power 68 · $51.0M mcap · 33M float · 0.549% daily turnover · Short 35% of daily vol
Smart Money Score
Moderate 50
Insider+$0.2M
Congress—
ETF Holdings—
Key Statistics
Market Cap$51.0M
52W Range0.501-1.6
Volume202,570
Avg Volume180,407
Beta1.36
Dividend—
Analyst Ratings
7 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOHeather Getz
Employees218
SectorHealthcare
IndustryMedical - Devices
IPO Date2019-11-07
1 Great Valley Parkway
Malvern, PA 19355
US
484 320 2930
About TELA Bio, Inc.

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Recent Insider Trades

NameTypeSharesPriceDate
Capper Joseph H P-Purchase 25,000 $1.22 2026-09-17
Capper Joseph H P-Purchase 50,000 $1.17 2026-09-16
Capper Joseph H P-Purchase 50,000 $1.06 2026-09-15
Capper Joseph H P-Purchase 25,000 $1.02 2026-09-14
Getz Heather C P-Purchase 12,500 $0.66 2026-08-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms